TLR4/CD14/MD2 Revealed As the Limited Toll-like Receptor Complex for -Induced NF-κB Signaling
Overview
Authors
Affiliations
is the most common cause of genital tract infections as well as preventable blindness worldwide. Pattern recognition receptors such as toll-like receptors (TLRs) represent the initial step in recognizing pathogenic microorganisms and are crucial for the initiation of an appropriate immune response. However, our understanding of TLR-signaling in -infected immune cells is incomplete. For a better comprehension of pathological inflammatory responses, robust models for interrogating TLR-signaling upon chlamydial infections are needed. To analyze the TLR response, we developed and utilized a highly sensitive and selective fluorescent transcriptional cellular reporter system to measure the activity of the transcription factor NF-κB. Upon incubation of the reporter cells with different preparations of , we were able to pinpoint which components of TLRs are involved in the recognition of . We identified CD14 associated with unique characteristics of different serovars as the crucial factor of the TLR4/CD14/MD2 complex for -mediated activation of the NF-κB pathway. Furthermore, we found the TLR4/CD14/MD2 complex to be decisive for the uptake of -derived lipopolysaccharides but not for infection and replication of . Imaging flow cytometry provided information about inclusion formation in myeloid- as well as lymphocytic cells and was highest for L2 with at least 25% of inclusion forming cells. E inclusion formation was eminent in Jurkat cells without CD14 expression (11.1%). Thus, our model enables to determine uptake and signal induction by pinpointing individual components of the recognition and signaling pathways to better understand the immune response towards infectious pathogens.
Chen Y, Li Z, Bai L, Lu B, Peng Y, Xu P FEBS Open Bio. 2024; 14(6):1011-1027.
PMID: 38604998 PMC: 11148121. DOI: 10.1002/2211-5463.13800.
Seroprevalence of and associated risk factors among HIV positive women in North Central Nigeria.
Omosigho P, Ajide T, Izevbuwa O, Okesanya O, Oladejo J, Uyigue P Infez Med. 2024; 32(1):52-60.
PMID: 38456033 PMC: 10917553. DOI: 10.53854/liim-3201-7.